Glycemic control and blood product quality of Canadian blood donors with diabetes
Transfusion · 2026-07 · 66 (7) · 1347-1357
DOI: 10.1111/trf.70223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 16.04.2026. Verfasst von Elyn M Rowe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Blood Donors, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Glycemic Control. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Blood Services.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Many blood centers now accept donors with diabetes, provided their condition is “well‐controlled”. However, glycemic control is not routinely assessed at donation, and the impact of donor diabetes on blood product quality remains unclear. Study Design and Methods To screen glycemic control, glycated hemoglobin A1c (HbA1c) was measured in whole blood from 256 unique donors with either type 1 diabetes (T1D), type 2 diabetes (T2D), or without known diabetes. In parallel, routine quality control (QC) data were linked with donor metadata to assess the impact of donor diabetes on red cell concentrate (RCC) and apheresis platelet concentrate (PC) quality at the time of their expiry.
Results
Nearly half of donors with diabetes had suboptimal glycemic control (HbA1c >7 %) at donation, including 57.1 % of donors with T1D and 43.4 % with T2D. RCC units from donors with T2D ( n = 1,329) had higher hemolysis ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Innovation and Portfolio Management, Canadian Blood Services, Edmonton, Alberta, Canada.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Medical Affairs and Innovation, Canadian Blood Services, Ottawa, Ontario, Canada.
- Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Elyn M Rowe, Mindy Goldman, Jason P Acker, James D Johnson
Förderung
- Canadian Blood Services
Zitieren
APA
Rowe, E. M., Shew, M., Ali-Mohamad, N., Phan, C., Goldman, M., Acker, J. P., Devine, D. V., & Johnson, J. D. (2026). Glycemic control and blood product quality of Canadian blood donors with diabetes. Transfusion, 66(7), 1347-1357. https://doi.org/10.1111/trf.70223
Vancouver
Rowe EM, Shew M, Ali-Mohamad N, Phan C, Goldman M, Acker JP, et al. Glycemic control and blood product quality of Canadian blood donors with diabetes. Transfusion. 2026;66(7):1347-1357. doi:10.1111/trf.70223
BibTeX
@article{Rowe2026,
author = {Rowe, Elyn M and Shew, Marcus and Ali-Mohamad, Noor and Phan, Celina and Goldman, Mindy and Acker, Jason P and Devine, Dana V and Johnson, James D},
title = {Glycemic control and blood product quality of Canadian blood donors with diabetes},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {7},
pages = {1347--1357},
doi = {10.1111/trf.70223}
}
EUVIMED